Search
01/06/2024
Lp(a) and coronary artery calcium associates to a distinctive miRNA signature in patients with familial hypercholesterolemia and subclinical atherosclerosis
Escate, R, Padró, T, Mata, P, Muñoz-Torrero, JS, Diaz-Diaz, J, Badimon, L. Lp(a) and coronary artery calcium associates to a distinctive miRNA signature in patients with familial hypercholesterolemia and subclinical atherosclerosis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024
Protective effects of intravenous atorvastatin on the axis ischemic heart to the brain: Preclinical study in pigs
Magaldi, M, Borrell, M, Alcover, S, Ramos, L, Arderiu, G, Casani, L, Padro, T, Badimon, L, Vilahur, G. Protective effects of intravenous atorvastatin on the axis ischemic heart to the brain: Preclinical study in pigs. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
29/05/2024
miRNA signature related to atherosclerotic lesion induced shear stress modifications in familial hypercholesterolemia patients with subclinical atherosclerosis: a bioinformatics systems biology study
Padro, T, Escate, R, De Isla, LP, Muniz-Grijalbo, O, Mata, P, Badimon, L. miRNA signature related to atherosclerotic lesion induced shear stress modifications in familial hypercholesterolemia patients with subclinical atherosclerosis: a bioinformatics systems biology study. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.170. PMID:. IF:13.300(Q1/1D).
20/05/2024
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Devaux, Y, Zhang, L, Lumley, AI, Karaduzovic-Hadziabdic, K, Mooser, V, Rousseau, S, Shoaib, M, Satagopam, V, Adilovic, M, Srivastava, PK, Emanueli, C, Martelli, F, Greco, S, Badimon, L, Padro, T, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Brandenburger, T, Benczik, B, Agg, B, Ferdinandy, P, Vehreschild, JJ, Lorenz-Depiereux, B, Dorr, M, Witzke, O, Sanchez, G, Kul, S, Baker, AH, Fagherazzi, G, Ollert, M, Wereski, R, Mills, NL, Firat, H. Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality. Nature Communications. 2024; 15(1)DOI:10.1038/s41467-024-47557-1. PMID:38769334. IF:15.700(Q1/1D).
01/05/2024
Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients
Escate, R, Padró, T, de Isla, LP, Fuentes, F, Alonso, R, Mata, P, Badimon, L. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients. ATHEROSCLEROSIS. 2024; 392DOI:10.1016/j.atherosclerosis.2024.117502. PMID:38513437. IF:5.700(Q1/1D).
16/04/2024
MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine
Ministrini, S, Padro, T. MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(7)DOI:10.1111/eci.14223. PMID:38623918. IF:3.600(Q1/2D).
27/03/2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
Arnold, N, Blaum, C, Gossling, A, Brunner, FJ, Bay, B, Ferrario, MM, Brambilla, P, Cesana, G, Leoni, V, Palmieri, L, Donfrancesco, C, Padró, T, Andersson, J, Jousilahti, P, Ojeda, F, Zeller, T, Linneberg, A, Söderberg, S, Iacoviello, L, Gianfagna, F, Sans, S, Veronesi, G, Thorand, B, Peters, A, Tunstall-Pedoe, H, Kee, F, Salomaa, V, Schnabel, RB, Kuulasmaa, K, Blankenberg, S, Koenig, W, Waldeyer, C. C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project. EUROPEAN HEART JOURNAL. 2024; 45(12)DOI:10.1093/eurheartj/ehad867. PMID:38240386. IF:35.600(Q1/1D).
13/03/2024
Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function
Borrell-Pages, M, Luquero, A, Vilahur, G, Padró, T, Badimon, L. Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function. CARDIOVASCULAR RESEARCH. 2024; 120(2)DOI:10.1093/cvr/cvad159. PMID:37882606. IF:13.300(Q1/1D).